Trials / Unknown
UnknownNCT01181518
Tamoxifen Pharmacogenetics in Asian Breast Cancer Women
Observational Study: Biomarker Research for Tamoxifen Pharmacogenetics Among Asian Breast Cancer Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Inje University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The clinical outcome of tamoxifen treatment in breast cancer patients may be influenced by the activity of cytochrome P450 enzymes involving in tamoxifen biotransformation.
Detailed description
The investigators investigated the prognostic and/or predictive value of genetic polymorphisms of enzymes involved in tamoxifen metabolism for the treatment outcome among Asian breast cancer patients.
Conditions
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2014-12-01
- Completion
- 2015-12-01
- First posted
- 2010-08-13
- Last updated
- 2013-06-03
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01181518. Inclusion in this directory is not an endorsement.